Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases

BACKGROUND: In patients undergoing major liver resection, portal vein embolization (PVE) has been widely used to induce hypertrophy of the non-embolized liver in order to prevent post-hepatectomy liver failure. PVE is a safe and effective procedure, but does not always lead to sufficient hypertrophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshayes, Emmanuel, Piron, Lauranne, Bouvier, Antoine, Lapuyade, Bruno, Lermite, Emilie, Vervueren, Laurent, Laurent, Christophe, Pinaquy, Jean-Baptiste, Chevallier, Patrick, Dohan, Anthony, Rode, Agnès, Sengel, Christian, Guillot, Chloé, Quenet, François, Guiu, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304136/
https://www.ncbi.nlm.nih.gov/pubmed/32560632
http://dx.doi.org/10.1186/s12885-020-07065-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304136/
https://www.ncbi.nlm.nih.gov/pubmed/32560632
http://dx.doi.org/10.1186/s12885-020-07065-z

Ejemplares similares